Mei-Jie Yang

No ORCID on file · 4 papers in corpus
other 2023
Factors influencing USgHIFU ablation for adenomyosis with NPVR ≥ 50
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group ·doi:10.1080/02656736.2023.2211753

OBJECTIVE: To investigate the influencing factors of ultrasound-guided HIFU (USgHIFU) ablation for adenomyosis with a non-perfused volume ratio (NPVR)≥50%. METHODS: A total of 299 patients with adenomyosis who underwent USgHIFU ablation we…

observational 2022
Factors influencing treatment decisions in HIFU treatment of adenomyosis: A retrospective study
Frontiers in surgery ·doi:10.3389/fsurg.2022.941368

OBJECTIVE: To explore the influencing factors of decision-making in patients with adenomyosis, who are receiving high-intensity focused ultrasound (HIFU) treatment. METHODS: A total of 776 patients with adenomyosis were enrolled into HIFU …

observational 2022
Ultrasound-guided HIFU for uterine fibroids of hyperintense on T2-weighted MR imaging with or without GnRH-analogue-pretreated: A propensity score matched cohort study
Frontiers in surgery ·doi:10.3389/fsurg.2022.975839

OBJECTIVE: To compare the therapeutic effect of high-intensity focused ultrasound (HIFU) ablation and HIFU pretreated with gonadotropin-releasing hormone analogue (GnRH-a) in the treatment of hyperintense uterine fibroids on T2-weighted mag…

other 2021
A Prediction of NPVR ≥ 80% of Ultrasound-Guided High-Intensity Focused Ultrasound Ablation for Uterine Fibroids
Frontiers in surgery ·doi:10.3389/fsurg.2021.663128

Objective: To evaluate factors in predicting the treatment outcome of ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation for uterine fibroids with a non-perfused volume ratio (NPVR) of at least 80%. Methods: One thousand…